Characteristics and limitations of national antimicrobial surveillance according to sales and claims data.
<h4>Purpose</h4>Antimicrobial use (AMU) is estimated at the national level by using sales data (S-AMU) or insurance claims data (C-AMU). However, these data might be biased by generic drugs that are not sold through wholesalers (direct sales) and therefore not recorded in sales databases...
Guardado en:
Autores principales: | Yoshiki Kusama, Yuichi Muraki, Chika Tanaka, Ryuji Koizumi, Masahiro Ishikane, Daisuke Yamasaki, Masaki Tanabe, Norio Ohmagari |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e3b869556c34f9db3e7a75ce095fe62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
por: Yoshiaki Gu, et al.
Publicado: (2021) -
Temporal changes in trauma according to alcohol sale restrictions during the South African national COVID-19 lockdown
por: Daniel J. van Hoving, et al.
Publicado: (2021) -
Claims on Ready-to-Eat Cereals: Are Those With Claims Healthier?
por: María Parra-Murillo, et al.
Publicado: (2021) -
Suggestion of a simpler and faster influenza-like illness surveillance system using 2014–2018 claims data in Korea
por: HeeKyoung Choi, et al.
Publicado: (2021) -
The Sale with Repurchase Clause
por: Urs,Ilie
Publicado: (2010)